WASHINGTON, D.C., APRIL 10–11, 2007

  • ANL Perspective on Conversion of Mo-99 Production from High to Low Enriched Uranium, George Vandegrift, Argonne National Laboratory (ANL)

  • Commercial Production of Fission Mo-99 from LEU Targets in Argentina, Pablo Cristini and Marcelo Salvatore, Comisión Nacional de Energia Atómica (CNEA) and INVAP (Investigaciones Aplicadas Sociedad del Estado)

  • Commercial Production of Fission Radioisotopes from LEU Targets in Argentina, Pablo Cristini, CNEA

  • FDA’s Regulatory Role in Medical Isotope Production, Orhan Suleiman, Food and Drug Administration (FDA)

  • NRC’s Process for Licensing Exports of Highly Enriched Uranium (HEU) Medical Isotope Target Material, Stephen Dembek, U.S. Nuclear Regulatory Commission (NRC)

  • Highly Enriched Uranium (HEU) Exports for Medical Isotope Production, Edward T. Fei, NNSA

  • Conversion of Molybdenum-99 (Mo-99) Production to LEU Target Technology, Grant Malkoske, MDS Nordion

  • Mallinckrodt’s Mo-99 Process & Progress to LEU Conversion, Dale Simpson, Tyco Healthcare/Mallinckrodt

  • Ion Beam Applications: Past, Present, and Future, Henri Bonet, Institute National des Radioéléments (IRE)

WASHINGTON, D.C., JUNE 11–12, 2007

  • Global Threat Reduction Initiative–Reactor Conversion Program– Molybdenum-99 Production with LEU, Parrish Staples, DOE-NNSA

  • Drug Master File Development and FDA Filings for LEU-Produced Medical Radionuclides, Roy Brown, CORAR

  • Cardinal Health Nuclear Pharmacy Services, Jack Coffey, Cardinal Health

  • The Cost of Developing Imaging Agents for Routine Clinical Use, Adrian Nunn, Bracco Research

  • Status of IAEA Mo-99 Activities, Ira Goldman, IAEA

  • National Academy of Sciences: Medical Isotope Production Study, Ralph Butler, University of Missouri Research Reactor (MURR)

  • AECL’s Medical Isotope Production, Brian McGee, Atomic Energy of Canada Limited (AECL)



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement